Respiratory distress (RD) is one of the most common reasons for babies to be admitted to neonatal intensive care unit (NICUs) 1 and 20% of those with severe RD die in low and middle-resource countries. 2,3 High-resource settings benefit from the availability of technologically advanced treatment options to support neonates with RD. In contrast, respiratory support is often restricted to oxygen therapy, delivered by low-flow nasal cannulas or face masks, in low and middle-resource settings. 4,5 Continuous positive airway pressure (CPAP) is widely used to treat respiratory diseases in neonates and can be implemented on large scale in low-resource settings. This is because it is simple, safe and less expensive than more advanced methods of respiratory support. 2